News & Updates

Show Multimedia Only

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

04 Oct 2022 by

The selective, oral sodium–glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (HFmrEF or HFpEF) in the phase III DELIVER* trial, touted as the largest and most inclusive thus far in this patient group.

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

04 Oct 2022

Add-on apatinib puts brakes on disease progression in advanced TNBC

03 Oct 2022

The addition of apatinib to vinorelbine appears to prolong progression-free survival in patients with advanced triple-negative breast cancer (TNBC) with failed first- or second-line treatment, as shown in the results of a phase II study.

Add-on apatinib puts brakes on disease progression in advanced TNBC

03 Oct 2022

Palaeolithic diet-induced weight loss extends benefits to sleep apnoea in women

03 Oct 2022 by

High adherence to the palaeolithic diet helps reduce sleep apnoea in menopausal women who are overweight, with the benefit linked to weight loss, according to a secondary analysis of a trial comparing a 2-year intervention of a palaeolithic diet with a low-fat control diet according to the Nordic Nutritional Recommendations.

Palaeolithic diet-induced weight loss extends benefits to sleep apnoea in women

03 Oct 2022

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

03 Oct 2022

Utilization of hearts donated after circulatory death (DCD) appears to result in transient post-transplant right heart dysfunction and short-term clinical outcomes otherwise comparable to transplantation using hearts donated after brain death (DBD), reveals a recent study.

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

03 Oct 2022

Infliximab reintroduction effective in some Crohn's disease patients

03 Oct 2022 by

Retreatment with infliximab (IFX) appears safe and effective in nearly a third of patients with Crohn’s disease (CD), independent of the reason for prior discontinuation, results of a study have shown.

Infliximab reintroduction effective in some Crohn's disease patients

03 Oct 2022

5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy

03 Oct 2022

Adjuvant therapy with 5-fluorouracil and low-molecular weight heparin (LMWH) is not superior to placebo in the prevention of proliferative vitreoretinopathy (PVR) in eyes with rhegmatogenous retinal detachment (RRD), reports a study.

5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy

03 Oct 2022

PLD-apatinib combo show promise for ovarian cancer

03 Oct 2022 by

A combination regimen comprising apatinib, a small-molecule TKI*, and pegylated liposomal doxorubicin (PLD) led to improved progression-free survival (PFS) in women with platinum-resistant recurrent ovarian cancer (PROC), results of the APPROVE trial suggest.

PLD-apatinib combo show promise for ovarian cancer

03 Oct 2022

Women, diabetics more likely to suffer from delayed gastric emptying after gastrectomy

03 Oct 2022 by

Among patients who undergo distal gastrectomy for gastric cancer, the risk of developing delayed gastric emptying (DGE) appears to be higher among women and those with diabetes, according to a recent study.

Women, diabetics more likely to suffer from delayed gastric emptying after gastrectomy

03 Oct 2022

Acupuncture eases anxiety in patients with Parkinson’s disease

03 Oct 2022

Acupuncture appears to be beneficial in the treatment of anxiety in patients with Parkinson’s disease, according to a study.

Acupuncture eases anxiety in patients with Parkinson’s disease

03 Oct 2022

Reproductive factors implicated in atrial fibrillation risk in women

03 Oct 2022

Reproductive factors such as irregular menstrual cycles, nulliparity, and multiparity contribute to an increased risk of new-onset atrial fibrillation in women, as reported in a study.

Reproductive factors implicated in atrial fibrillation risk in women

03 Oct 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Add-on apatinib puts brakes on disease progression in advanced TNBC

Add-on apatinib puts brakes on disease progression in advanced TNBC

Palaeolithic diet-induced weight loss extends benefits to sleep apnoea in women

Palaeolithic diet-induced weight loss extends benefits to sleep apnoea in women

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

Infliximab reintroduction effective in some Crohn's disease patients

Infliximab reintroduction effective in some Crohn's disease patients

5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy

5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy

PLD-apatinib combo show promise for ovarian cancer

PLD-apatinib combo show promise for ovarian cancer

Women, diabetics more likely to suffer from delayed gastric emptying after gastrectomy

Women, diabetics more likely to suffer from delayed gastric emptying after gastrectomy

Acupuncture eases anxiety in patients with Parkinson’s disease

Acupuncture eases anxiety in patients with Parkinson’s disease

Reproductive factors implicated in atrial fibrillation risk in women

Reproductive factors implicated in atrial fibrillation risk in women